Regenerative Medical Technology Group Inc.
For the period ended Dec 31, 2024. Filed Apr 15, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Apr 15, 2025
RMTGStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
| ITEM 15. | EXHIBITS FINANCIAL STATEMENT SCHEDULES. |
|---|
We have filed the exhibits listed on the accompanying Exhibit Index of this registration statement and below in this Item 15:
| Incorporated by | |||||
|---|---|---|---|---|---|
| Reference · Filed or Furnished | |||||
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date | Herewith |
| 2.1 | Plan of Merger | 10-12G | 2.1 | 12/12/2018 | |
| 3.1 | Articles of Incorporation, as Amended | 10-12G | 3.1 | 12/12/2018 | |
| 3.2 | Series AA Certificate of Designation | 10-12G | 3.2 | 12/12/2018 | |
| 3.3 | Series BB Certificate of Designation | 10-12G | 3.3 | 12/12/2018 | |
| 3.4 | Amendment to Certificate of Designation of Series AA Preferred Stock | 8-K | 3.1 | 11/29/2019 | |
| 3.5 | Certificate of Designation of Series CC Preferred Stock | 8-K | 3.2 | 11/29/2019 | |
| 3.6 | Certificate of Designation of Series DD Preferred Stock | 8-K | 3.3 | 11/29/2019 | |
| 3.7 | Amendment to Certificate of Designation of Series AA Preferred Stock | 8-K | 3.1 | 6/24/2021 | |
| 3.8 | Withdrawal of Certificate of Designation for Series BB Preferred Stock | 10-K | 3.8 | 4/15/2024 | |
| 3.9 | Withdrawal of Certificate of Designation for Series CC Preferred Stock | 10-K | 3.9 | 4/15/2024 | |
| 3.10 | Certificate of Designation for Series CC Preferred Stock dated April 10, 2025 | X | |||
| 3.11 | Amended and Restated Bylaws | 8-K | 3.4 | 11/29/2019 | |
| 4.1 | Promissory Note, dated December 9, 2020 to JCC Trading, LLC | 10-K | 4.2 | 4/14/2023 | |
| 4.2 | Promissory Note, dated January 6, 2021 to JCC Trading, LLC | 10-K | 4.3 | 4/14/2023 | |
| 4.3 | Senior Secured Promissory Note dated June 22, 2021 with Growth Ventures | 10-K | 4.4 | 4/14/2023 | |
| 4.4 | Promissory Note dated September 20, 2021 with Growth Ventures | 10-K | 4.5 | 4/14/2023 | |
| 4.5 | Description of Securities Registered | X | |||
| 4.6 | Secured Promissory Note, dated April 10, 2025 | X | |||
| 4.7 | Warrant to Purchase Stock, dated April 10, 2025 | X | |||
| 10.1 | Binding Letter of Intent | 8-K | 10.1 | 07/15/2019 | |
| 10.2 | Exchange Agreement of Series BB Convertible Stock | 8-K | 10.1 | 11/29/2019 | |
| 10.3 | Repurchase Agreement | 8-K | 10.1 | 11/29/2019 | |
| 10.4 | Stock Purchase Agreement | 8-K | 10.2 | 6/24/2021 | |
| 10.5 | Consulting Agreement | 8-K | 10.1 | 8/19/2021 | |
| 10.6 | Debt Restructure Agreement, dated December 7, 2020 with JCC Trading, LLC | 10-K | 10.5 | 4/14/2023 | |
| 10.7 | Debt Restructure Agreement, dated December 7, 2020 with Eagle Equities, LLC | 10-K | 10.6 | 4/14/2023 | |
| 10.8 | Debt Restructure Agreement, dated December 7, 2020 with Union Capital, LLC | 10-K | 10.7 | 4/14/2023 | |
| 10.9 | Loan Agreement dated December 9, 2020 with JCC Trading, LLC | 10-K | 10.8 | 4/14/2023 | |
| 10.10 | Loan Agreement dated December 30, 2021 with JCC Trading, LLC | 10-K | 10.9 | 4/14/2023 | |
| 10.11 | Loan Agreement dated December 30, 2021 with JCC Trading, LLC | 10-K | 10.10 | 4/14/2023 | |
| 10.12 | Equity Financing Agreement, dated December 8, 2023 | 8-K | 10.1 | 12/13/23 | |
| 10.13 | Registration Rights Agreement, dated December 8, 2023 | 8-K | 10.2 | 12/13/23 | |
| 10.14 | Placement Agent Agreement with Icon, dated December 8, 2023 | 8-K | 10.3 | 12/13/23 | |
| 10.15 | Secured Loan Agreement, dated April 10, 2025 | X | |||
| 21.1 | List of Subsidiaries | 10-12G | 21.1 | 12/12/2018 | |
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. | X | |||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended. | X | |||
| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350. | X | |||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Linkbase Document. | X | |||
| 101.CAL | Inline XBRL Taxonomy Calculation Linkbase Document. | X | |||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. | X | |||
| 101.LAB | Inline XBRL Taxonomy Label Linkbase Document. | X | |||
| 101.PRE | Inline XBRL Taxonomy Presentation Linkbase Document. | X | |||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.